Skip to main navigation Skip to search Skip to main content

A genome-wide association meta-analysis of all-cause and vascular dementia

  • The Mega Vascular Cognitive Impairment and Dementia (MEGAVCID) consortium
  • , Bernard Fongang
  • , Muralidharan Sargurupremraj
  • , Xueqiu Jian
  • , Aniket Mishra
  • , Vincent Damotte
  • , Itziar de Rojas
  • , Olivia Skrobot
  • , Joshua C. Bis
  • , Kang Hsien Fan
  • , Erin Jacobsen
  • , Gloria Hoi Yee Li
  • , Jingyun Yang
  • , Bizzarro Alessandra
  • , Lauria Alessandra
  • , Saima Hilal
  • , Joyce Ruifen Chong
  • , Yuek Ling Chai
  • , M. J. Knol
  • , Maria Pina Concas
  • Girotto Giorgia, Moeen Riaz, Chenglong Yu, Alexander Guojonsson, Paul Lacaze, Adam C. Naj, Monica Gireud-Goss, Yannick N. Wadop, Aicha Soumare, Vincent Bouteloup, Vilmundur Gudnason, Petronilla Battista, Aurora Santin, Beatrice Spedicati, Rodolfo Sardone, Lenore Launer, Jan Bressler, Rebecca F. Gottesman, Quentin Le Grand, Ilana Caro, Gennady V. Roshchupkin, Hampton L. Leonard, Chaojie Yang, Traci M. Bartz, Constance Bordes, Paul M. Ridker, Mirjam I. Geerlings, Natalie C. Gasca, Ani Manichaikul, Mike A. Nalls, Pekka Karhunen

Research output: Contribution to journalArticleScientificpeer-review

42 Citations (Scopus)
13 Downloads (Pure)

Abstract

INTRODUCTION: Dementia is a multifactorial disease with Alzheimer's disease (AD) and vascular dementia (VaD) pathologies making the largest contributions. Yet, most genome-wide association studies (GWAS) focus on AD. METHODS: We conducted a GWAS of all-cause dementia (ACD) and examined the genetic overlap with VaD. Our dataset includes 800,597 individuals, with 46,902 and 8702 cases of ACD and VaD, respectively. Known AD loci for ACD and VaD were replicated. Bioinformatic analyses prioritized genes that are likely functionally relevant and shared with closely related traits and risk factors. RESULTS: For ACD, novel loci identified were associated with energy transport (SEMA4D), neuronal excitability (ANO3), amyloid deposition in the brain (RBFOX1), and magnetic resonance imaging markers of small vessel disease (SVD; HBEGF). Novel VaD loci were associated with hypertension, diabetes, and neuron maintenance (SPRY2, FOXA2, AJAP1, and PSMA3). DISCUSSION: Our study identified genetic risks underlying ACD, demonstrating overlap with neurodegenerative processes, vascular risk factors, and cerebral SVD. Highlights: We conducted the largest genome-wide association study of all-cause dementia (ACD) and vascular dementia (VaD). Known genetic variants associated with AD were replicated for ACD and VaD. Functional analyses identified novel loci for ACD and VaD. Genetic risks of ACD overlapped with neurodegeneration, vascular risk factors, and cerebral small vessel disease.

Original languageEnglish
Pages (from-to)5973-5995
Number of pages23
JournalAlzheimer's and Dementia
Volume20
Issue number9
DOIs
Publication statusPublished - Sept 2024
Publication typeA1 Journal article-refereed

Funding

We thank the many study participants, researchers, and staff for collecting and contributing to the data. This project was conducted within the neurology working group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. The CHARGE cohorts are supported in part by the National Heart, Lung, and Blood Institute (NHLBI) infrastructure grants R01HL105756 (Psaty), RC2HL102419 (Boerwinkle) and the neurology working group is supported by the National Institute on Aging (NIA) R01 grant AG033193. Additional funding sources include the UT Health San Antonio Center for Biomedical Neuroscience (CBN) and grants from the NIA (AG059421, AG054076, AG049607, AG033090, AG066524, P30 AG066546, 5P30AG059305\u201003, RF1 AG061729A1, 5U01AG052409\u201004) and NINDS (NS017950, UF1NS125513, K01NS126489). Funding sources for each cohort are listed in Supplementary File 2 . Agustin Ruiz and Itziar de Rojas acknowledge research support from Grifols SA (Spain), Fundacion Bacaria LaCaixa (Spain), Instituto de Salud Carlos III Ministry of Health (Spain), Roche, and Janssen. Agustin Ruiz received consulting fees and honoraria from Landsteiner Genmed SL, Grifols SA, and Janssen; support for attending meetings from Grifols SA; and stock options from Landsteiner Genmed SL. All authors report no conflicts of interest. Additional author disclosures are available in the supporting information (Supplementary File 2 ).

FundersFunder number
UT Health San Antonio Center for Biomedical Neuroscience
National Heart, Lung, and Blood Institute
Roche Oy
Janssen Pharmaceutica NV
Fundacion Bacaria LaCaixa
Instituto de Salud Carlos III Ministry of Health
CBNAG059421, 5U01AG052409‐04, AG054076, 5P30AG059305‐03, RF1 AG061729A1, P30 AG066546, AG049607, AG033090, AG066524
National Institute on AgingAG033193
National Institute on Aging
NHLBI Framingham Heart StudyRC2HL102419, R01HL105756
National Institute of Neurological Disorders and Stroke (NINDS)K01NS126489, NS017950, UF1NS125513

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • all-cause dementia
    • Alzheimer's disease
    • cross-ancestry
    • genome-wide association study (GWAS)
    • GWAS meta-analysis
    • vascular dementia

    Publication forum classification

    • Publication forum level 3

    ASJC Scopus subject areas

    • Epidemiology
    • Health Policy
    • Developmental Neuroscience
    • Clinical Neurology
    • Geriatrics and Gerontology
    • Cellular and Molecular Neuroscience
    • Psychiatry and Mental health

    Fingerprint

    Dive into the research topics of 'A genome-wide association meta-analysis of all-cause and vascular dementia'. Together they form a unique fingerprint.

    Cite this